04/11/2024
8:44 AM | Harmony Biosciences (Filer)
| Form ARS | |
04/11/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:17 AM | Harmony Biosciences (Filer)
| Form DEF 14A | |
04/11/2024
7:18 AM | Harmony Biosciences (Filer)
| Form DEFA14A | |
03/18/2024
6:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:17 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/08/2024
3:21 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:16 PM | Harmony Biosciences (Filer)
| Form 10-K/A | |
02/22/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:06 PM | Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
| Form SC 13G/A | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SC 13G/A | |
01/08/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
7:59 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/08/2023
8:03 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
7:15 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
7:31 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
10/11/2023
7:15 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SC 13G/A | |
10/05/2023
3:15 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:15 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
7:12 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/25/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:59 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/14/2023
3:42 PM | Harmony Biosciences (Filer)
| Form 8-K/A | |
08/28/2023
7:23 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T | |
08/24/2023
4:23 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC 13D | |
08/14/2023
4:26 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/14/2023
4:27 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:29 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/01/2023
7:01 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2023
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
3:37 PM | Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
| Form 4/A | |
05/26/2023
4:25 PM | Harmony Biosciences (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
3:20 PM | Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
05/26/2023
3:26 PM | Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023
7:20 AM | Harmony Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/02/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
